BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 28231420)

  • 1. Serum ferritin concentration predicts hepatic fibrosis better than hepatic iron concentration in human HFE-Haemochromatosis.
    Wood MJ; Crawford DHG; Wockner LF; Powell LW; Ramm GA
    Liver Int; 2017 Sep; 37(9):1382-1388. PubMed ID: 28231420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes.
    Cheng R; Barton JC; Morrison ED; Phatak PD; Krawitt EL; Gordon SC; Kowdley KV
    J Clin Gastroenterol; 2009 Jul; 43(6):569-73. PubMed ID: 19359997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.
    Chitturi S; Weltman M; Farrell GC; McDonald D; Kench J; Liddle C; Samarasinghe D; Lin R; Abeygunasekera S; George J
    Hepatology; 2002 Jul; 36(1):142-9. PubMed ID: 12085358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis.
    Adams LA; Angulo P; Abraham SC; Torgerson H; Brandhagen D
    Liver Int; 2006 Apr; 26(3):298-304. PubMed ID: 16584391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis.
    Crawford DH; Murphy TL; Ramm LE; Fletcher LM; Clouston AD; Anderson GJ; Subramaniam VN; Powell LW; Ramm GA
    Hepatology; 2009 Feb; 49(2):418-25. PubMed ID: 19177571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steatosis is a cofactor in liver injury in hemochromatosis.
    Powell EE; Ali A; Clouston AD; Dixon JL; Lincoln DJ; Purdie DM; Fletcher LM; Powell LW; Jonsson JR
    Gastroenterology; 2005 Dec; 129(6):1937-43. PubMed ID: 16344062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis.
    Valenti L; Maggioni P; Piperno A; Rametta R; Pelucchi S; Mariani R; Dongiovanni P; Fracanzani AL; Fargion S
    World J Gastroenterol; 2012 Jun; 18(22):2813-20. PubMed ID: 22719190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of hepatic or total body iron burden in the assessment of advanced hepatic fibrosis in HFE hemochromatosis.
    Chin J; Powell LW; Ramm LE; Ayonrinde OT; Ramm GA; Olynyk JK
    Sci Rep; 2019 Dec; 9(1):20234. PubMed ID: 31882912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duration of hepatic iron exposure increases the risk of significant fibrosis in hereditary hemochromatosis: a new role for magnetic resonance imaging.
    Olynyk JK; St Pierre TG; Britton RS; Brunt EM; Bacon BR
    Am J Gastroenterol; 2005 Apr; 100(4):837-41. PubMed ID: 15784029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum ferritin level predicts advanced hepatic fibrosis among U.S. patients with phenotypic hemochromatosis.
    Morrison ED; Brandhagen DJ; Phatak PD; Barton JC; Krawitt EL; El-Serag HB; Gordon SC; Galan MV; Tung BY; Ioannou GN; Kowdley KV
    Ann Intern Med; 2003 Apr; 138(8):627-33. PubMed ID: 12693884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased risk of death from iron overload among 422 treated probands with HFE hemochromatosis and serum levels of ferritin greater than 1000 μg/L at diagnosis.
    Barton JC; Barton JC; Acton RT; So J; Chan S; Adams PC
    Clin Gastroenterol Hepatol; 2012 Apr; 10(4):412-6. PubMed ID: 22265917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical cofactors and hepatic fibrosis in hereditary hemochromatosis: the role of diabetes mellitus.
    Wood MJ; Powell LW; Dixon JL; Ramm GA
    Hepatology; 2012 Sep; 56(3):904-11. PubMed ID: 22422567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor-β and toll-like receptor-4 polymorphisms are not associated with fibrosis in haemochromatosis.
    Wood MJ; Powell LW; Dixon JL; Subramaniam VN; Ramm GA
    World J Gastroenterol; 2013 Dec; 19(48):9366-76. PubMed ID: 24409064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of body iron in HFE-related haemochromatosis and moderate iron overload (Mi-Iron): a multicentre, participant-blinded, randomised controlled trial.
    Ong SY; Gurrin LC; Dolling L; Dixon J; Nicoll AJ; Wolthuizen M; Wood EM; Anderson GJ; Ramm GA; Allen KJ; Olynyk JK; Crawford D; Ramm LE; Gow P; Durrant S; Powell LW; Delatycki MB
    Lancet Haematol; 2017 Dec; 4(12):e607-e614. PubMed ID: 29195602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between metabolic hyperferritinaemia, fibrosis-promoting alleles and clinical outcomes in steatotic liver disease.
    Suresh D; Li A; Miller MJ; Wijarnpreecha K; Chen VL
    Liver Int; 2024 Feb; 44(2):389-398. PubMed ID: 37971775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A population-based study of the clinical expression of the hemochromatosis gene.
    Olynyk JK; Cullen DJ; Aquilia S; Rossi E; Summerville L; Powell LW
    N Engl J Med; 1999 Sep; 341(10):718-24. PubMed ID: 10471457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cirrhosis in Hemochromatosis: Independent Risk Factors in 368 HFE p.C282Y Homozygotes.
    Barton JC; McLaren CE; Chen WP; Ramm GA; Anderson GJ; Powell LW; Subramaniam VN; Adams PC; Phatak PD; Gurrin LC; Phillips JD; Parker CJ; Emond MJ; McLaren GD
    Ann Hepatol; 2018 Aug; 17(5):871-879. PubMed ID: 30145563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GNPAT rs11558492 is not a Major Modifier of Iron Status: Study of Italian Hemochromatosis Patients and Blood Donors.
    Greni F; Valenti L; Mariani R; Pelloni I; Rametta R; Busti F; Ravasi G; Girelli D; Fargion S; Galimberti S; Piperno A; Pelucchi S
    Ann Hepatol; 2017; 16(3):451-456. PubMed ID: 28425416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ductular reaction in hereditary hemochromatosis: the link between hepatocyte senescence and fibrosis progression.
    Wood MJ; Gadd VL; Powell LW; Ramm GA; Clouston AD
    Hepatology; 2014 Mar; 59(3):848-57. PubMed ID: 24037895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations.
    Piperno A; Vergani A; Malosio I; Parma L; Fossati L; Ricci A; Bovo G; Boari G; Mancia G
    Hepatology; 1998 Oct; 28(4):1105-9. PubMed ID: 9755249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.